Momenta

What Momenta does

Momenta is a Brazilian pharmaceutical company established in 2013 as a prescription-focused brand within Grupo Eurofarma, headquartered in São Paulo with manufacturing operations in Itapevi. Its portfolio spans three core product lines: prescription medications across psychiatry, gynecology, respiratory, pain management, orthopedics, andrology (including lisdexamfetamine and methylphenidate for ADHD), and antibiotics in the penicillinic, carbapenemic, and cephalosporinic classes for human and veterinary use; OTC medications such as expectorants and laxatives; and a nutraceutical/supplement range (brands include Prosso, Quelatus, Bemove, 20 BI, UmBi, Mag+, Kelus) covering probiotics, bone, joint, cognitive, and women's health.

The business operates a sales-led go-to-market targeting physicians, nutritionists, and consumers through pharmacy/drugstore distribution, a consumer-facing "Pertinho de Mim" online storefront, a B2B portal for registered resellers, and dedicated digital visitation programs (Nutrivisita for nutritionists). Manufacturing is anchored in an ANVISA GMP-, MAPA-, ISO 14001-, Invima (Colombia)-, and Digemid (Peru)-certified plant, enabling cross-border distribution of Momenta-branded generics within the parent Eurofarma group, which operates in more than 20 countries. Revenue streams are all transactional one-time-unit sales of physical pharmaceutical, OTC, and nutraceutical SKUs; publicly listed consumer pricing shows promotions roughly 10% off list (e.g., Prosso from R$ 104.30 to R$ 92.50).

In 2023–2025 the company extended beyond physical products, launching an alopecia treatment (March 2023) and two AI-driven information tools for healthcare professionals — eBulas (June 2025) and infoDoctor (August 2025) — while integrating its medical-evidence content into the parent group's Euron Pro presscriber portal. Momenta is a 100% Brazilian privately held subsidiary of Eurofarma Laboratórios S.A., with employment in the 501–1,000 range and no independent external shareholders.

Name

Momenta

Legal name

Eurofarma Laboratórios S.A.

Website

https://momentafarma.com.br

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Momenta is a Brazilian pharmaceutical company, founded in 2013 as a brand within Grupo Eurofarma, that develops and distributes prescription generics, OTC medications, and nutraceutical supplements to physicians, nutritionists, and consumers across Latin America.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

• Prescription pharmaceuticals
• Generic medications
• Nutritional supplements
• Probiotic supplements
• Pharmaceutical manufacturing

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Prescription Medications: Sales of prescription-based pharmaceutical products including psychiatric, gynecological, respiratory, orthopedic, and pain management medications
2. OTC/Non-prescription Drugs: Over-the-counter medications and health supplements available without prescription including probiotics, expectorants, and digestive health products
3. Nutraceuticals and Food Supplements: Dietary supplements including vitamins, minerals, probiotics, and specialized nutritional products for bone health, cognitive function, and general wellness

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Momenta Farmacêutica is a Brazilian pharmaceutical company that manufactures and distributes a diversified portfolio of bioequivalent generic prescription medications, over-the-counter (OTC) drugs, and branded nutritional supplements/nutraceuticals (Prosso, Quelatus, Bemove, 20 BI, UmBi Gotas, Emama). The company sells its products through a B2B portal to pharmacies and distributors, physical pharmacy networks across Brazil, and a direct-to-consumer online store, while operating digital engagement programs such as Nutrivisita for nutritionists and AI tools (infoDoctor, eBulas) for healthcare professionals.

Product overview

Momenta is a Brazilian pharmaceutical company founded in 2013 as part of Eurofarma Group, operating as a multi-category pharmaceutical portfolio. The company offers three main product lines: Prescription Medications (Prescrição Médica) for psychiatric conditions, gynecology, respiratory, pain management, and chronic diseases; Non-Prescription Medications (Isentos de Prescrição) including expectorants, laxatives, and menopause treatments; and Nutritional Supplements/Nutraceuticals including probiotics (20 BI, UmBi Gotas, 10 Bi Imune), bone health supplements (Prosso, Prosso KM, Prosso D+KM), joint health (Bemove), mineral supplements (Quelatus line, Mag+ Quelatus), and specialized supplements for pregnancy, seniors, and bariatric patients. The company also provides digital services including the Nutrivisita program for nutritionist visits and AI-powered tools (infoDoctor and eBulas) for healthcare professionals.

Differentiator

Problem solved

Functional benefit

Brands

• Prosso: Vitamin-mineral supplement for calcium and vitamin D3 needs
• 20 BI
• Bemove
• UmBi Gotas
• Quelatus
• Quelatus Senior
• Quelatus Bari
• Quelatus Mulher
• Quelatus Mind
• Quelatus Gest
• Prosso KM

Products and services

• Prosso Bone Health Supplements Vitamin-mineral bone health supplement line: Prosso (calcium citrate malate + vitamin D), Prosso KM (+ vitamin K2), Prosso D+KM (+ vitamin D3, K2, and magnesium bisglycinate chelate), and Prosso Muscular (high-bioavailability calcium citrate malate + magnesium bisglycinate) for bone, teeth, and muscle health maintenance. Consumer-priced, publicly listed on the Momenta website (e.g., R$ 92.50 after discount).
• Quelatus Nutritional Formulas Balanced nutritional formula line with amino-acid chelated minerals targeting different life stages and conditions: Quelatus (base formula for irregular/deficient diets), Quelatus Bari (post-bariatric procedure support), Quelatus Mind FOS (cognitive deficit support), Quelatus Mulher (women's nutritional needs across ages), Quelatus Sênior (50+ nutritional balance), and Quelatus Gest (pregnancy and lactation with fish oil omega-3 and high choline).
• Bemove Joint & Connective Tissue Supplements Joint and connective tissue health supplements: Bemove (non-denatured type II collagen + eggshell membrane extract/NEM for skin, tendons, cartilage, and bone health) and Bemove Curcuma (with curcumin for adult use 19+).
• 20 BI Probiotic Supplements Probiotic gut-health line: 20 BI (20 billion microorganisms per capsule across 5 colonizing strains including Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium lactis Bl-04) and 20 BI Fibras (same probiotic strains combined with prebiotic FOS fiber) for intestinal microbiota balance and gastrointestinal health.
• 10 Bi Imune Probiotic Probiotic supplement with 10 billion CFU of Lactobacillus rhamnosus GG plus Vitamin D for immune system strengthening and intestinal flora balance.
• UmBi Gotas Infant Probiotic Probiotic drops with Bifidobacterium animalis subsp. lactis BB-12 for infants from 0 months, indicated to relieve gastric discomfort, colic, diarrhea, and constipation.
• Emama Vitamin E Supplements Vitamin E antioxidant supplement line in capsules (Emama) and softgels (Emama Gama) to protect against free radical damage.
• Mag+ Quelatus Magnesium Supplement Magnesium bisglycinate chelate nutritional supplement supporting muscle and neuromuscular function, cardiovascular health, and reducing cramps.
• Generic Prescription Pharmaceuticals Diversified portfolio of bioequivalent generic prescription medications sold through pharmacies in Brazil and across Latin America, covering psychiatry (sertraline, citalopram, lisdexamfetamine, methylphenidate for ADHD), gynecology (danazol, postmenopausal osteoporosis treatment, diosmin/hesperidin vascular therapy), respiratory system (amoxicillin/clavulanate antibiotics, expectorants), pain management (ketoprofen, tramadol/paracetamol, celecoxib, ketorolac, pregabalin for neuropathic pain and fibromyalgia, muscle relaxants), orthopedics (irbesartan/HCTZ, osteoarthritis/rheumatoid arthritis treatment), and other therapeutic areas. Targeted at physicians who prescribe and at pharmacies and distributors who dispense these medications.
• Over-the-Counter (OTC) Medications Over-the-counter medication line including expectorants (Aires XPE for respiratory conditions with viscous secretions and paracetamol intoxication), laxatives (Minilax sorbitol-based intestinal constipation and post-operative bowel normalization; Minilax Pediátrico for children), coadjuvant therapy for menopause symptoms (Buona — hot flashes and night sweats), and silicone-based scar gel (Kelus for closed wounds and keloid prevention post-surgery/trauma/burns).
• Nutrivisita Digital Visitation Program Digital visitation program offering online visits to nutritionists presenting Momenta's nutraceutical product portfolio and discussing scientific updates and clinical content. Serves as the company's primary digital engagement channel for licensed nutritionists (CRN-registered) in Brazil.
• infoDoctor AI Platform Artificial intelligence platform for healthcare professionals providing intelligent information retrieval capabilities, supporting clinical and scientific information access as part of Momenta's healthcare professional engagement ecosystem.
• eBulas AI Tool Artificial intelligence system that uses AI to facilitate access to and improve retrieval of medication package insert (bula) information for healthcare professionals and patients, supporting Momenta's broader healthcare professional engagement and patient education strategy.

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature2 records

Partnerships

One partnership is on record.

• Grupo EurofarmacoreOthersParent company that created Momenta in 2013. Momenta operates as a brand under Eurofarma, sharing ethical positioning, values, and corporate principles. The company leverages Eurofarma's manufacturing capabilities, distribution infrastructure, and operational resources.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Hypera Pharma: Largest Brazilian pharmaceutical company by market cap, with a broad portfolio of branded generics, OTCs, and consumer health brands. Comparable business model across prescription, OTC, and supplement segments, with similar retail and prescriber channels.
• Arese Pharma: Brazilian pharmaceutical manufacturer with prescription generics, women's health, and dermatology focus. Comparable mid-tier scale, ANVISA manufacturing footprint, and reliance on pharmacy distribution channels.
• Biolab Farmacêutica: Brazilian mid-cap pharmaceutical manufacturer focused on branded generics and prescription medications across cardiology, gynecology, and pediatrics. Comparable scale, therapeutic breadth, and ANVISA-driven regulatory exposure.
• Aché Laboratórios: Brazilian pharmaceutical company with prescription drugs, generics, and consumer health products. Comparable therapeutic breadth and similar multi-channel go-to-market approach targeting the same prescriber and pharmacy ecosystem.
• EMS: Brazil's largest generics-focused pharmaceutical manufacturer, offering prescription drugs, OTCs, and branded generics across overlapping therapeutic categories (psychiatry, gynecology, respiratory). Directly comparable on channel mix, prescriber targets, and ANVISA-driven regulatory exposure.
• Libbs Farmacêutica: Brazilian pharmaceutical manufacturer with prescription drugs concentrated in gynecology, dermatology, and cardiology. Comparable scale, channel mix (pharmacy + B2B), and therapeutic focus on women's health adjacencies.

Broad incumbents

• Pfizer: Global pharmaceutical major with established Brazilian commercial operations. Overlaps with Momenta in select prescription categories but operates at vastly larger scale and with proprietary patented products, serving as a reference point on category economics.
• Bayer: Global pharmaceutical and consumer health company with established Brazilian presence including supplements, OTC, and prescription products. Comparable in consumer health and OTC but at materially greater scale and broader geographic diversification.
• Sanofi: Global pharmaceutical major with significant Brazilian commercial operations spanning consumer health, vaccines, and prescription drugs. Overlaps with Momenta in OTC and supplement categories but operates at much larger scale with proprietary patented assets.

Others

• Eurofarma Laboratórios: Parent company of Momenta and one of Brazil's largest pharmaceutical conglomerates, operating in 20+ countries with branded generics, prescription drugs, and hospital products. Direct line-of-sight into Momenta's manufacturing footprint, distribution, and strategic direction.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/momentafarma
• Facebookfacebook.com/momentafarma

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Momenta